Amundi Simulations Plus, Inc. Transaction History
Amundi
- $253 Billion
- Q2 2024
A detailed history of Amundi transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Amundi holds 932 shares of SLP stock, worth $29,413. This represents 0.0% of its overall portfolio holdings.
Number of Shares
932Holding current value
$29,413% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding SLP
# of Institutions
180Shares Held
15.9MCall Options Held
3.9KPut Options Held
200-
Black Rock Inc. New York, NY2.46MShares$77.8 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC2.26MShares$71.4 Million1.67% of portfolio
-
Neuberger Berman Group LLC New York, NY1.27MShares$40.1 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$36.4 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX836KShares$26.4 Million2.84% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $641M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...